跳至主要内容
临床试验/NCT04856436
NCT04856436已完成不适用

Maternal and Neonatal Outcomes Following Benzodiazepine Use During Pregnancy

Sungkyunkwan University1 个研究点 分布在 1 个国家目标入组 3,094,227 人开始时间: 2020年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
3,094,227
试验地点
1
主要终点
Risk of congenital malformations

研究概览

简要总结

This is a nationwide cohort study to assess maternal and neonatal outcomes following exposure to benzodiazepines during pregnancy.

详细描述

Benzodiazepines are widely used in pregnant women; however, their safety on congenital malformations in a real-world setting is still uncertain. We aimed to assess the association between benzodiazepine use in early pregnancy and the risk of congenital malformations. We will conduct a retrospective nationwide cohort study using the Health Insurance Review and Assessment (HIRA) database of South Korea, which covers the entire South Korean population.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnancies with live birth, 2011-2018
  • Pregnancies linked to liveborn infants
  • Pregnancies aged 20-45 years at delivery

排除标准

  • Pregnancies with a chromosomal abnormality
  • Pregnancies with exposure to known teratogenic drugs (e.g. antineoplastic agent, warfarin, lithium, isotretinoin, misoprostol, thalidomide) during the first trimester
  • Pregnancies with no benzodiazepine prescription during the first trimester, but with at least one benzodiazepine prescription during the 3 months before the pregnancy onset

研究组 & 干预措施

Pregnant women with exposure to benzodiazepines

Women who gave birth during 2011-2018, were aged 20-45 years and were filled at least one benzodiazepine prescription during the first trimester (first 90 days of pregnancy).

干预措施: Benzodiazepine (Drug)

Pregnant women without exposure to benzodiazepines

Women who gave birth during 2011-2018, were aged 20-45 years and did not fill a benzodiazepine prescription during the 3 months before the pregnancy onset through the end of the first trimester

干预措施: Benzodiazepine (Drug)

结局指标

主要结局

Risk of congenital malformations

时间窗: from the birth date until up to 8 years, death, or study end date (Dec 31, 2019)

Overall congenital malformations and organ-specific congenital malformations in infants, which are confirmed by diagnostic records in the HIRA database. All infants were followed up for at least 1 year.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ju-Young Shin

Associate Professor

Sungkyunkwan University

研究点 (1)

Loading locations...

相似试验